These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 8996050)

  • 1. Is the course of neurocysticercosis modified by treatment with anthelmintic agents?
    Del Brutto OH
    Arch Intern Med; 1997 Jan; 157(1):128-30. PubMed ID: 8996050
    [No Abstract]   [Full Text] [Related]  

  • 2. Praziquantel in neurocysticercosis.
    Mehndiratta MM; Gupta M
    J Assoc Physicians India; 1989 Apr; 37(4):298. PubMed ID: 2613633
    [No Abstract]   [Full Text] [Related]  

  • 3. Neurocysticercosis.
    Barry M; Kaldjian LC
    Semin Neurol; 1993 Jun; 13(2):131-43. PubMed ID: 8356346
    [No Abstract]   [Full Text] [Related]  

  • 4. Intramedullary cysticercosis cured with drug treatment. A case report.
    Corral I; Quereda C; Moreno A; López-Vélez R; Martínez-San-Millán J; Guerrero A; Sotelo J
    Spine (Phila Pa 1976); 1996 Oct; 21(19):2284-7. PubMed ID: 8902977
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neurocysticercosis: treatment with albendazole and dextrochloropheniramine (preliminary report).
    Agapejev S; Meira DA; Barraviera B; Machado JM; Pereira PC; Mendes RP; Kamegasawa A; Curi PR
    Rev Inst Med Trop Sao Paulo; 1988; 30(5):387-9. PubMed ID: 3074454
    [No Abstract]   [Full Text] [Related]  

  • 6. Albendazole therapy for neurocysticercosis.
    Takayanagui OM
    Neurology; 1998 Mar; 50(3):834-5. PubMed ID: 9521303
    [No Abstract]   [Full Text] [Related]  

  • 7. Albendazole therapy for neurocysticercosis.
    Ko DY; Chang GY
    Neurology; 1998 Mar; 50(3):834-5. PubMed ID: 9521302
    [No Abstract]   [Full Text] [Related]  

  • 8. Antihelminthic therapy for neurocysticercosis.
    Kramer LD
    Arch Neurol; 1990 Oct; 47(10):1059-60. PubMed ID: 2222234
    [No Abstract]   [Full Text] [Related]  

  • 9. Albendazole versus praziquantel for neurocysticercosis.
    Mehta SS; Hatfield S; Jessen L; Vogel D
    Am J Health Syst Pharm; 1998 Mar; 55(6):598-600. PubMed ID: 9544338
    [No Abstract]   [Full Text] [Related]  

  • 10. [Neurocysticercosis complicating the treatment of cutaneous cysticercosis in a traveller].
    Epelboin L; Klement E; Chemali N; Danis M; Bricaire E; Caumes E
    Bull Soc Pathol Exot; 2004 Nov; 97(4):250-2. PubMed ID: 17304744
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cerebral and subcutaneous cysticercosis treated with albendazole.
    Schmidt DK; Jordaan HF; Schneider JW; Cilliers J
    Int J Dermatol; 1995 Aug; 34(8):574-9. PubMed ID: 7591443
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Drug treatment of neurocysticercosis.
    Garg RK
    Natl Med J India; 1997; 10(4):173-7. PubMed ID: 9325640
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Subcutaneous nodules preceding convulsions due to neural cysticercosis.
    Singrodia S; Joshi RG; Solanki RB; Rawal RC
    Indian J Dermatol Venereol Leprol; 2008; 74(4):385-6. PubMed ID: 18797066
    [No Abstract]   [Full Text] [Related]  

  • 14. Neurocysticercosis--an update.
    Maiti B
    J Assoc Physicians India; 1995 Jul; 43(7):477-82. PubMed ID: 8713223
    [No Abstract]   [Full Text] [Related]  

  • 15. [Results of sequential prolonged courses of albendazole and praziquantel in recurrent neurocysticercosis].
    Alla P; Carli P; Paris JF; Chagnon A
    Med Trop (Mars); 1996; 56(3):308. PubMed ID: 9026603
    [No Abstract]   [Full Text] [Related]  

  • 16. Albendazole in neurocysticercosis.
    Padma MV; Behari M; Misra NK; Ahuja GK
    Natl Med J India; 1995; 8(6):255-8. PubMed ID: 8520442
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neurocysticercosis: optimal dose treatment with albendazole.
    Cruz I; Cruz ME; Carrasco F; Horton J
    J Neurol Sci; 1995 Nov; 133(1-2):152-4. PubMed ID: 8583218
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Short course of albendazole therapy for neurocysticercosis.
    Sotelo J; Penagos P; Escobedo F; Del Brutto OH
    Arch Neurol; 1988 Oct; 45(10):1130-3. PubMed ID: 3178533
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anthelmintic activity of mebendazole against Cysticercus fasciolaris.
    Thienpont D; Vanparijs O; Hermans L
    J Parasitol; 1974 Dec; 60(6):1052-3. PubMed ID: 4436749
    [No Abstract]   [Full Text] [Related]  

  • 20. Albendazole and praziquantel treatment in neurocysticercosis of the fourth ventricle.
    Proaño JV; Madrazo I; García L; García-Torres E; Correa D
    J Neurosurg; 1997 Jul; 87(1):29-33. PubMed ID: 9202261
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.